ClearNote Health Bolsters Leadership Team with Oncology and Diagnostics Veterans
Event summary
- ClearNote Health appointed Jeffrey Venstrom, MD, as Chief Medical Officer to lead clinical development and medical affairs.
- Daniel Black, DBA, joined as General Manager of International Markets to drive global commercial adoption.
- Irene Hsieh was promoted to Vice President of Regulatory Affairs and Quality Assurance to advance regulatory pathways.
- Jeremy Bennett was hired as Head of Marketing to oversee brand strategy and go-to-market execution.
The big picture
ClearNote Health is positioning itself for broader clinical adoption and global expansion by assembling a leadership team with deep expertise in oncology, diagnostics, and regulatory affairs. The appointments come as the company builds on the success of its Avantect Pancreatic Cancer Test, aiming to shift oncology from late-stage intervention to proactive early detection. The strategic hires underscore ClearNote Health's focus on translating breakthrough science into real-world clinical impact.
What we're watching
- Clinical Validation
- How Dr. Venstrom's leadership will accelerate the generation of real-world evidence for ClearNote Health's early cancer detection tests.
- Regulatory Pathways
- Whether Irene Hsieh can successfully navigate regulatory submissions and ensure compliance with global standards.
- Global Expansion
- The pace at which Daniel Black can scale ClearNote Health's commercial presence in international markets.
Our editorial coverage:
Related topics